44 results
Page 2 of 3
424B5
nomsfn1tum
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
qqv3 788q4et
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
S-3
o6kqk9zpws9 vpmve0
1 Jun 22
Shelf registration
4:06pm
8-K
EX-99.1
02h8jl0t
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
8-K
EX-99.2
6llyvt40xhprw 5hqxjp
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
DEF 14A
cxrtzrbs
28 Apr 22
Definitive proxy
4:44pm
8-K
EX-99.1
0a64ndak5w94n8k j29
13 Apr 22
Targeted Therapies for People of All Ages April 2022
8:01am
10-K
hjfog4w7g7r pq7
7 Mar 22
Annual report
7:36am
8-K
EX-99.2
d5yt6bm8hr79rydg jko
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
8-K
lur 2u2g09ptdvo13orc
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am
8-K
EX-99.2
aoky1qwflazgez
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am
10-Q
x8urbmtbgr9z hg
10 Aug 21
Quarterly report
5:26pm
8-K
EX-99.2
xxcle5oqbf 98
10 Aug 21
Day One Reports Second Quarter 2021 Financial Results and Corporate Progress
4:15pm
424B4
ikl3pduliz65fzzy oz4
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
zcj73kafle8uojre
24 May 21
IPO registration (amended)
6:16am
S-1
od7qihr tyf53
4 May 21
IPO registration
4:12pm
S-1
EX-10.5
mzo42rjp5lflfm unew
4 May 21
IPO registration
4:12pm